Anima secures €11m in Series A funding led by Molten Ventures to expand its healthcare platform
The Y Combinator alumnus has raised capital from Molten Ventures, Hummingbird, and Amino Collective to scale its clinical operating system.
≈ £9.4M at €1 = £0.8540 on 19 Mar 2024
London-based developer of a care enablement platform that unifies clinic, network, and regional healthcare workflows.
Anima has secured €11m in a Series A funding round led by Molten Ventures. The capital injection also drew participation from Hummingbird Ventures, Amino Collective, Y Combinator, and angel investors including Sidar Sahin.
The London-based healthcare technology company will direct the funds towards accelerating the rollout of its clinical platform to millions of patients and medical professionals internationally. The investment arrives as clinics grapple with acute financial pressures and administrative burdens, particularly within the National Health Service.
Founded in 2021, the firm provides a universal operating system designed to streamline patient triage, documentation, and care coordination. The company plans to use the proceeds to support upcoming software releases focused on office automation and data interoperability.
From the founder
"We’re excited to bring Inga of Molten on our journey. From day one, it was clear to us that she shared our vision of care enablement, a thesis Inga and Molten have had for years. I’m deeply grateful for the special crew we have at Anima. This is a passion project – we’re building what we wish we had as doctors and patients. No one is here just to do a job. We all serve a greater purpose – and that’s why ultimately we’ll continue to move mountains."
Shun Pang
Co-founder and CEO at Anima
Investor perspective
"Software and artificial intelligence (AI) in healthcare is a rapidly growing multi-$bn sector, but many solutions take time to integrate and realise their potential. A key reason why Anima is growing rapidly, is because they can directly and immediately have an impact: to improve operations and efficiency to benefit patients, healthcare teams and healthcare systems. This team understands the relevant workflows, the needs of patients and healthcare workers, and is building a large, scalable engine for change."
Inga Deakin
Partner, Molten
Use of funds
- 01Expand into international markets
- 02Continue product development
